Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02429375 · COMPLETED
Trial details
- NCT number
- NCT02429375
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-22
- Primary completion
- 2021-02-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.